Differential regulation of prostaglandin synthesis in neonatal rat microglia and astrocytes by somatostatin

European Journal of Pharmacology

Volumn 584, Issue 2-3, 2008, Pages 312-317

  Grinshpun, Julia ^a   Tveria, Liat ^a   Fleisher Berkovich, Sigal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Astrocytes; Lipopolysaccharide; Microglia; Prostaglandin E2; Somatostatin

Indexed keywords

HORMONE RECEPTOR STIMULATING AGENT; L 779976; L 796778; L 803087; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; SOMATOSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; REGULATORY MECHANISM;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; LIPOPOLYSACCHARIDES; MICROGLIA; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 41349103186     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.025     Document Type: Article

References (42)

1. Aguila M.C., Dees W.L., Haensly W.E., and McCann S.M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 11485-11489
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van-Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2 (2000) 383-421
3. Alderton F., Fan T.P., and Humphrey P.P. Somatostatin receptor-mediated arachidonic acid mobilization: evidence for partial agonism of synthetic peptides. Br. J. Pharmacol. 32 (2001) 760-766
4. Aloisi F. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol. 468 (1999) 123-133
5. Benveniste E.N., Nguyen V.T., and O`Keefe G.M. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39 (2001) 381-391
6. Bhathena S.J., Louie J., Schechter G.P., Redman R.S., Wahl L., and Recant L. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes 30 (1981) 127-131
7. Bozou J.C., de Nadai F., Vincent J.P., and Kitabgi P. Neurotensin, bradykinin and somatostatin inhibit cAMP production in neuroblastoma N1E115 cells via both pertussis toxin sensitive and insensitive mechanisms. Biochem. Biophys. Res. Commun. 161 (1989) 1144-1150
8. Brenner T., Boneh A., Shohami E., Abramsky O., and Weidenfeld J. Glucocorticoid regulation of eicosanoid production by glial cells under basal and stimulated conditions. J. Neuroimmunol. 40 (1992) 273-280
9. Chen Y., and Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23 (2003) 137-149
10. Colas B., Arilla E., and Prieto J.P. Somatostatin binding to a fresh rat astrocyte-enriched suspension. Neuropeptides 23 (1992) 1-7
11. Davis K., Mohs R., Marin D.B., Purohit D.P., Perl D.P., Lantz M., Austin G., and Haroutunian V. Neuropeptide abnormalities in patients with early Alzheimer's disease. Arch. Gen. Psychiatry 56 (1999) 981-987
12. Epelbaum J., Dournaud P., Fodor M., and Viollet C. The neurobiology of somatostatin. Crit. Rev. Neurobiol. 81 (1994) 25-44
13. Fassbender K., Walter S., Kuhl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., Rivest S., Lentschat A., Gulbins E., Jucker M., Staufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T., and Beyreuther K. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 18 (2004) 203-205
14. Feindt J., Becker I., Blomer U., Hugo H.H., Mehdorn H.M., Krisch B., and Mentlein R. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J. Neurochem. 65 (1995) 1997-2005
15. Feindt J., Schmidt A., and Mentlein R. Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells. Brain Res. Mol. Brain Res. 60 (1998) 228-233
16. Florio T., Yao H., Carey K.D., Dillon T.J., and Stork P. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR 1). Mol. Endocrinol. 13 (1999) 24-37
17. Gonzalez B.J., Leroux P., Braquet P., and Vaudry H. Pharmacological characterization of somatostatin receptors in the rat cerebellum during development. J. Neurochem. 55 (1990) 729-737
18. Grimaldi M., Florio T., and Schettini G. Somatostatin inhibits IL-6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase. Biochem. Biophys. Res. Com. 235 (1997) 242-248
19. Hull M., Muksch B., Akundi R.S., Waschbisch A., Hoozemans J.J.M., Veerhuis R., and Fiebich B.L. Amyloid β peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes. Neurochem. Int. 48 (2006) 663-672
20. int' Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M., and Stricker B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345 (2001) 1515-1521
21. Karalis K., Mastorakos G., Sano H., Wilder R.L., and Chrousos G.P. Somatostatin may participate in the antiinflammatory action of glucocorticoids. Endocrinology 136 (1995) 4133-4138
22. 2 in rat astrocyte cultures: modulatory effect of neuropeptides. Endocrinology 124 (1989) 3125-3127
23. Levant A., Levy E., Argaman M., and Fleisher-Berkovich S. Kinins and neuroinflammation: dual effect on prostaglandin synthesis. Eur. J. Pharmacol. 546 (2006) 197-200
24. Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., Schulz-Schaeffer, W., Fassbender, K., in press. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging.
25. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304 (2003) 1-7
26. Masmoudi O., Gandolfo P., Tokay T., Leprince J., Ravni A., Vaudry H., and Tonon M.C. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. J. Neurochem. 94 (2005) 561-571
27. Moller L.N., Stidsen C.E., Hartmann B., and Holst J.J. Somatostatin receptors. Biochim. Biophys. Acta 1616 (2003) 1-84
28. Montine, T.J., Sidell, K.R., Crews, B.C., Markesbery, W.R., Marnett, L.J., Roberts, L.J., Morrow, J.D., 1999. Elevated CSF prostaglandin E2 levels in patients with probable AD. 53, 1495-1498.
29. Murphy W.J. Effects of GH, Insulin like growth factor, and somatostatin on immune function and development. In: Marsh J.A., and Kendall M.D. (Eds). The physiology of immunity (1996), CRC Press, Boca Raton 197-209
30. Nickels D., Schwab N., and Poth M. Effects of somatostatin and captopril on glomerular prostaglandin E2 production in normal and diabetic rats. Prostaglandins 46 (1993) 61-73
31. Noda M., Sasaki K., Ifuku M., and Wada K. Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects. Neurochem. Int. 51 (2007) 185-191
32. O'Banion M.K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 13 (1999) 45-82
33. Oka A., and Takashima S. Induction of cyclooxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurons and axons. NeuroReport 8 (1997) 1161-1164
34. Patrizio M., Costa T., and Levi G. Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase. Glia 14 (1995) 94-100
35. Peluso G., Petillo O., Melone M.A.B., Mazzarella G., Ranieri M., and Tajana G.F. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides 30 (1996) 443-451
36. Pyo H., Yang M.S., Jou I., and Joe E.H. Wortmannin enhances lipopolysaccharide-induced inducible nitric oxide synthase expression in microglia in the presence of astrocytes in rats. Neurosci. Lett. 346 (2003) 141-144
37. Reardon D.B., Dent P., Wood S.L., Kong T., and Sturgill T.W. Activation in vitro of somatostatin receptor subtypes 2,3 or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol. Endocrinol. 11 (1997) 1062-1069
38. Reichlin S. Somatostatin I. New Engl. J. Med. 309 (1983) 1495-1501
39. Rohrer S.P., and Schaeffer J.M. Identification and characterization of subtype selective somatostatin receptor agonists. J. Physiol. (Paris) 94 (2000) 211-215
40. Scicchitano R., Dazin P., Bienenstock J., Payan D.G., and Stanisz A.M. The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. J. Immunol. 141 (1988) 937-941
41. Smalley K.S., Feniuk W., Sellers L.A., and Humphrey P.P. The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst (4) receptor-mediated stimulation of p42/p44 mitogen-activated protein kinase and extracellular acidification. Biochem. Biophys. Res. Commun. 263 (1999) 239-243
42. Valatas V., Kolios G., Manousou P., Xidakis C., Notas G., Dusanka L., and Kouroumalis E.A. Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide. Regulatory Pept. 120 (2004) 215-225